Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Net Cash Flow (2013 - 2026)

Xencor (XNCR) posted quarterly Net Cash Flow of -$40.0 million for Q1 2026, down 2969.92% year-over-year from $1.4 million in Q1 2025, and down 255.14% quarter-over-quarter from $25.8 million in Q4 2025.

Analysis

Xencor (XNCR) Net Cash Flow (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Net Cash Flow for 14 consecutive years, with -$40.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Cash Flow fell 2969.92% year-over-year to -$40.0 million; the TTM figure through Mar 2026 stood at -$25.6 million (down 399.64% YoY), while the FY2025 annual figure was $13.1 million, up 201.49% from the prior year.
  • Net Cash Flow declined to -$40.0 million in Q1 2026 per XNCR's latest filing, from $25.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $25.8 million in Q4 2025 and bottomed at -$65.2 million in Q1 2022.
  • Historically, Net Cash Flow has averaged -$7.6 million across 5 years, with a median of -$264000.0 in 2024.
  • Annual changes were most pronounced in 2025 — Net Cash Flow soared 1906.44% — and 2026, when it slumped 2969.92%.
  • Xencor's Net Cash Flow stood at $1.3 million in 2022, then declined by 17.78% to $1.1 million in 2023, then jumped by 1018.6% to $11.8 million in 2024, then soared by 117.65% to $25.8 million in 2025, then slumped by 255.14% to -$40.0 million in 2026.
  • Business Quant data shows XNCR's Net Cash Flow at -$40.0 million in Q1 2026, $25.8 million in Q4 2025, and -$16.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Xencor 2.02 Bn 1.65 Bn - 30.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.49 Mn
Mar 31, 2026 -40.00 Mn
Dec 31, 2025 25.78 Mn
Sep 30, 2025 -16.15 Mn
Jun 30, 2025 4.77 Mn
Mar 31, 2025 -1.30 Mn
Dec 31, 2024 11.85 Mn
Sep 30, 2024 -1.74 Mn
Jun 30, 2024 -264,000.00
Mar 31, 2024 -22.75 Mn
Dec 31, 2023 1.06 Mn
Sep 30, 2023 18.40 Mn
Jun 30, 2023 -37.68 Mn
Mar 31, 2023 18.45 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 3.24 Mn
Jun 30, 2022 -28.86 Mn
Mar 31, 2022 -65.21 Mn
Dec 31, 2021 102.28 Mn
Sep 30, 2021 -74.64 Mn